| Aneri Patel, MD | |
|
6821 Pines Rd, Suite 100, Shreveport, LA 71129-2547 | |
| (318) 687-5500 | |
| (318) 687-5503 |
| Full Name | Aneri Patel |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 13 Years |
| Location | 6821 Pines Rd, Shreveport, Louisiana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053677674 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD.207915 (Louisiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Honorhealth Scottsdale Shea Medical Center | Scottsdale, AZ | Hospital |
| John C. Lincoln North Mountain Hospital | Phoenix, AZ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Honorhealth Medical Group, Llc | 1557274057 | 224 |
| Bhsm Rehabilitation Llc | 2062773138 | 1258 |
News Archive
Otonomy, Inc., a clinical stage biopharmaceutical company developing innovative therapeutics for diseases and disorders of the inner and middle ear, today announced that researchers presented positive new data from a Phase 1b study of the company's lead product candidate, OTO-104, in patients with Meniere's disease.
Temple University Hospital is now participating in a variety of clinical trials that are testing investigational treatment options for patients diagnosed with the novel coronavirus, or COVID-19.
Inflammatory breast cancer (IBC) is a very rare and aggressive disease that progresses rapidly and is associated with a very low survival rate. To understand how this type of cancer spreads, it's crucial to characterize the interactions between cancer cells and their 3D environment.
The world's first genetic sequencing of precancerous lung lesions could pave the way for very early detection and new treatments, reports a new study led by UCL researchers.
Viruses designed to target and kill cancer cells could boost the effectiveness of chemotherapy to the arms and legs and help avoid amputation, a new study reports.
› Verified 8 days ago
| Entity Name | Honorhealth Medical Group, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043851793 PECOS PAC ID: 1557274057 Enrollment ID: O20031119000717 |
News Archive
Otonomy, Inc., a clinical stage biopharmaceutical company developing innovative therapeutics for diseases and disorders of the inner and middle ear, today announced that researchers presented positive new data from a Phase 1b study of the company's lead product candidate, OTO-104, in patients with Meniere's disease.
Temple University Hospital is now participating in a variety of clinical trials that are testing investigational treatment options for patients diagnosed with the novel coronavirus, or COVID-19.
Inflammatory breast cancer (IBC) is a very rare and aggressive disease that progresses rapidly and is associated with a very low survival rate. To understand how this type of cancer spreads, it's crucial to characterize the interactions between cancer cells and their 3D environment.
The world's first genetic sequencing of precancerous lung lesions could pave the way for very early detection and new treatments, reports a new study led by UCL researchers.
Viruses designed to target and kill cancer cells could boost the effectiveness of chemotherapy to the arms and legs and help avoid amputation, a new study reports.
› Verified 8 days ago
| Entity Name | Honorhealth Ambulatory |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407050917 PECOS PAC ID: 5991603110 Enrollment ID: O20071005000449 |
News Archive
Otonomy, Inc., a clinical stage biopharmaceutical company developing innovative therapeutics for diseases and disorders of the inner and middle ear, today announced that researchers presented positive new data from a Phase 1b study of the company's lead product candidate, OTO-104, in patients with Meniere's disease.
Temple University Hospital is now participating in a variety of clinical trials that are testing investigational treatment options for patients diagnosed with the novel coronavirus, or COVID-19.
Inflammatory breast cancer (IBC) is a very rare and aggressive disease that progresses rapidly and is associated with a very low survival rate. To understand how this type of cancer spreads, it's crucial to characterize the interactions between cancer cells and their 3D environment.
The world's first genetic sequencing of precancerous lung lesions could pave the way for very early detection and new treatments, reports a new study led by UCL researchers.
Viruses designed to target and kill cancer cells could boost the effectiveness of chemotherapy to the arms and legs and help avoid amputation, a new study reports.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Aneri Patel, MD 6821 Pines Rd, Suite 100, Shreveport, LA 71129-2547 Ph: (318) 687-5500 | Aneri Patel, MD 6821 Pines Rd, Suite 100, Shreveport, LA 71129-2547 Ph: (318) 687-5500 |
News Archive
Otonomy, Inc., a clinical stage biopharmaceutical company developing innovative therapeutics for diseases and disorders of the inner and middle ear, today announced that researchers presented positive new data from a Phase 1b study of the company's lead product candidate, OTO-104, in patients with Meniere's disease.
Temple University Hospital is now participating in a variety of clinical trials that are testing investigational treatment options for patients diagnosed with the novel coronavirus, or COVID-19.
Inflammatory breast cancer (IBC) is a very rare and aggressive disease that progresses rapidly and is associated with a very low survival rate. To understand how this type of cancer spreads, it's crucial to characterize the interactions between cancer cells and their 3D environment.
The world's first genetic sequencing of precancerous lung lesions could pave the way for very early detection and new treatments, reports a new study led by UCL researchers.
Viruses designed to target and kill cancer cells could boost the effectiveness of chemotherapy to the arms and legs and help avoid amputation, a new study reports.
› Verified 8 days ago
Ratnam Baby Nagalla, M.D Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 870 Olive St, Shreveport, LA 71104 Phone: 318-629-0480 Fax: 318-629-0483 | |
David Juston Colvin, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 8383 Millicent Way, Shreveport, LA 71115 Phone: 318-797-6661 Fax: 318-795-8512 | |
Susan Michelle Self, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 8001 Youree Dr, Suite 540, Shreveport, LA 71115 Phone: 318-212-3810 Fax: 318-212-3815 | |
Dr. Kirk Anthony Grantham, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2530 Bert Kouns Loop, Suite 138, Shreveport, LA 71118 Phone: 318-588-4726 Fax: 318-900-7828 | |
Ayesha Tabassom, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1541 Kings Hwy, Shreveport, LA 71103 Phone: 318-626-0000 Fax: 318-629-4833 | |
David Henry, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 7813 Youree Dr, Shreveport, LA 71105 Phone: 318-212-3830 Fax: 318-212-3835 | |
Ammar Husan, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1541 Kings Hwy, Shreveport, LA 71103 Phone: 318-626-0000 |